Thaw FAQ.
Keeping tissue alive outside the body raises hard questions about time, medicine, and risk. Ask us all of them.
Are you freezing people?
No. We work on donated organs and tissue samples, never on whole bodies, and never after a legal death.
The curiosity behind the question is fair, though. Whole-body preservation has no reversible protocol today, and it would be dishonest of us to imply otherwise. Our scope is narrower and much nearer: holding a donated kidney, liver, or heart in a cold, glass-like state for days rather than the six or eight hours a cooler buys. Learn to do that reliably and the same physics eventually reaches larger and more fragile systems, including patients who have run out of waiting time.
Where is cold preservation used right now?
Embryos, blood products, corneas, and cell lines are already stored cold at scale, some for decades. Solid organs are the gap: they are large, layered, and vascular, so the same recipes crack them.
What actually happens to the tissue?
We perfuse the organ with a protective solution, drop the temperature fast enough that water sets into a glass instead of a crystal, then reverse the process with uniform warming so no region thaws ahead of its neighbours.
Has any of this been demonstrated?
In animal models, yes, and the published record is public. Rodent kidneys have been recovered after storage and gone on to support the animal alone. Human-scale organs are the next order of difficulty and we do not claim to have cleared it.
Does neural tissue behave differently?
It is the least forgiving tissue we handle: dense, poorly perfused at the margins, and unusually sensitive to the same solutions that protect a kidney. It sits outside our current programme.
Which patients would benefit first?
People waiting on a transplant list, and the surgeons who currently discard usable organs because the clock ran out mid-transit. Longer viability windows mean better matching, less waste, and fewer overnight flights.
Honestly — isn’t this a bit far-fetched?
Refrigerated transport sounded far-fetched once too. We are not asking anyone to believe a story; we publish protocols, failure rates, and the experiments that did not work.
Can university labs partner with you, or only industry?
Both. Roughly half of our active collaborations sit inside academic departments, and we share reagents and rewarming hardware with any group willing to publish what they find.
Where do I write about press, talks, or joint research?
One inbox handles all three: hello@torporlabs.bio. A named researcher replies, usually within two working days.
Are you selling immortality?
No, and we sell nothing to individuals at all. The goal is a wider window between recovery and surgery. That is a logistics problem with a medical payoff, not a promise about lifespan.
Where does this sit alongside today’s transplant networks?
Underneath it, not beside it. Recovery teams, allocation rules, and operating rooms stay exactly as they are; we are trying to change one variable, the hours an organ stays usable, and let the existing system do more with it.